Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips For those investors interested in small-cap stocks to buy, you might steer clear of tech names. At least, that’s according to the analysts at Jefferies . Jefferies analyst Steven DeSanctis recently dis...
NORTH BILLERICA, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc . (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative diagnostics, targeted therapeutics and artificial intelligence solutions that...
B Riley has resumed coverage of Lantheus Holdings ( NASDAQ: LNTH ) with a buy citing the company's growth trajectory due to the the launch of Pylarify, a prostate-specific membrane antigen (PSMA) targeting positron emission tomography ( PET ) imaging agent. The firm ha...
Earnings season winds down after producing the best S&P performance since 2009. The recently passed tax and spend green energy bill does not contain a scintilla of "growth". That means any recovery remains rocky at best. China's zero COVID policy continues to take its toll on ...
Stock market expectations have shifted to a relatively more benign Federal Reserve rate outlook, thus driving a sharp rally. The market is approaching a key technical level. Healthcare has relatively outperformed the market and has been consolidating. Biotechs found a bottom a...
As the market begins to show signs of recovery in the second half of 2022, there are 3 growth stocks that are offering investors a chance to realize capital appreciation. AerSale is about to commercialize its AerAware heads-up aircraft cockpit display technology and has realized a 72%...
Lantheus Holdings, Inc. (LNTH) Q2 2022 Earnings Conference Call Aug 4, 2022 8:08 AM Company Participants Mark Kinarney - Senior Director, Investor Relations Mary Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Lantheus Holdings, Inc. 2022 Q2 - Results - Earnings Call Presentation
The biotech industry for the first half of the year had seen better six-month periods in the past, but the situation appears to have changed beginning in July. From Jan. 1 to June 20, 2022, the SPDR S&P Biotech ETF ( XBI ) and iShares Nasdaq Biotechnology ETF ( IBB ) had...
Lantheus press release ( NASDAQ: LNTH ): Q2 Non-GAAP EPS of $0.89 beats by $0.19 . Revenue of $223.72M (+121.4% Y/Y) beats by $19.21M . Net cash provided by operating activities was $72.6 million for the second quarter 2022. Free cash flow was $68.3 million in ...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...